To Stop or Not To Stop: MS Disease Modifying Therapy
by John Corboy, MD, Michelle Dougherty, MD, Robert T. Naismith, MD
John Corboy, MD and Robert Naismith, MD probe the question of when to stop disease-modifying therapies in MS. They assess various factors to consider when discontinuing therapy and offer an update on new research to address the effects of therapy cessation.
Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.